Index. Infect Dis Clin N Am 19 (2005) Note: Page numbers of article titles are in boldface type.

Transcription

1 Infect Dis Clin N Am 19 (2005) Index Note: Page numbers of article titles are in boldface type. A Abstinence in genital herpes management, 436 Abuse sexual childhood sexual behavior effects of, Antiviral therapy in genital herpes management, Attitude(s) sexual behavior effects of, B Bacterial STDs prevention and control of innovative approaches to, See also Sexually transmitted diseases (STDs), bacterial, prevention and control of, innovative approaches to. Bacterial vaginosis, See also Vaginosis, bacterial. Behavior(s) sexual. See Sexual behavior. Behavioral interventions and control, C Cancer cervical screening for, CDC. See Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC), 352 Cervical cancer screening for, Cervical HPV infection oncogenic, See also Human papillomavirus (HPV) infection, cervical. Cervicitis mucopurulent, See also Mucopurulent cervicitis (MPC). Cervix anatomy and physiology of, Chlamydia trachomatis detection of new specimen types for, vaccines for, 478 Chlamydial infection clinical overview of, 283 epidemiology of, assessment of challenges to, 283 in special populations estimates of, microbiology of, 283 nucleic acid amplification tests for, See also Nucleic acid amplification tests, for chlamydia. prevalence of population-based estimates of, reported cases of, 287 screening for in males in bacterial STDs prevention and control, 522 surveillance for, 287 symptoms of, 287 Cluster tracing and control, 524, 527 Condom(s) in genital herpes management, /05/$ - see front matter Ó 2005 Elsevier Inc. All rights reserved. doi: /s (05) id.theclinics.com

2 564 INDEX Counseling for patients with genital HPV infection, See also Genital HPV infection, counseling for patients with. for patients with genital HSV infection, See also Genital HSV infection, counseling for patients with. risk-reduction in STD management in MCOs, Culture(s) for gonorrhea, 376 D Demography sexual behavior effects of, Direct smear examination for gonorrhea, E Expectation(s) sexual behavior effects of, F Fluoroquinolone(s) mechanisms of action of, Neisseria gonorrhoeae resistant to, See also Neisseria gonorrhoeae, fluoroquinolone-resistant. G Genital HPV infection counseling for patients with, external genital warts and, 472 key messages in, partners and, 472 pregnancy-related, 472 special considerations in, described, 467 educational challenge of, psychosocial aspects of, Genital HSV infection. See also Herpes simplex virus (HSV) infection, genital. counseling for patients with, Genital warts external in genital HPV infection counseling for patients with, 472 GISP. See Gonococcal Isolate Surveillance Project (GISP). Gonococcal Isolate Surveillance Project (GISP), 352 Gonorrhea clinical overview of, 288 epidemiology of, in special populations estimates of, 289 microbiology of, 288 nucleic acid amplification tests for, See also Nucleic acid amplification tests, for gonorrhea. prevalence of population-based estimates of, 288 reported cases of, surveillance for, H Herpes simplex virus (HSV) infection barriers to dialogue about, genital counseling for patients with, asymptomatic shedding in, 466 determination of length of infection in, importance of, in asymptomatic patients who test positive, 466 psychosocial adjustment and, described, , diagnosis of disclosure of, diagnostic tests for characteristics of, 430 damaging effects of, 434 during pregnancy, in general population, 434 in high-risk patients, in partners, 432 reliability of, serologic assays, identification of, 429 management of, antiviral therapy in, condoms in, 436 selective abstinence in, 436 medical importance of, 428 problems associated with,

3 transmission of management of, 435 talking with patients about, vaccines for, Herpes simplex virus (HSV) infection type 2 in HIV acquisition, Herpes simplex virus (HSV) type 2 in HIV prevention, in HIV spread, 417 in HIV transmission, 419 in outcomes of intervention trials for STDs, treatment of impact on HIV progression, Hierarchy sexual behavior effects of, 305 Homosexual men STDs in in Western Europe and U.S., See also Sexually transmitted diseases (STDs), in homosexual men, in Western Europe and U.S. HPV infection. See Human papillomavirus (HPV) infection. HSV infection. See Herpes simplex virus (HSV) infection. Human immunodeficiency virus (HIV) infection acquisition of HSV type 2 in, prevention of HSV type 2 in, progression of HSV type 2 treatment impact on, spread of HSV type 2 in, 417 transmission of HSV type 2 in, 419 Human immunodeficiency virus (HIV)/STDs interactions developments in, Human papillomavirus (HPV) infection cervical epidemiology of, natural history of, oncogenic, screening for, diagnostic tests for, vaccines for, Hybridization INDEX probe for gonorrhea, I Infection(s). See also specific types. sexually acquired in women Mycoplasma genitalium as, Internet-based interventions and control, 532 M Managed care organizations (MCOs) STD care in, See also Sexually transmitted diseases (STDs), treatment of, in MCOs. types of, 492 Mass treatment and control, Mental health sexual behavior effects of, Microbicide(s) and control, MPC. See Mucopurulent cervicitis (MPC). Mucopurulent cervicitis (MPC), causes of, controversy related to, 344 defined, epidemiology of, management of, future efforts related to, 344 nonchlamydial nongonococcal, Mycoplasma genitalium as sexually acquired infection in women, PID due to, See also Pelvic inflammatory disease (PID), causes of. N Neisseria gonorrhoeae fluoroquinolone-resistant, See also Fluoroquinolone(s). clinical significance of, determinant mechanisms in, epidemiology of,

4 566 INDEX Neisseria gonorrhoeae (continued ) future directions in, prevalence of, treatment of principles in, nucleic acid amplification tests for, 375 vaccines for, Nucleic acid amplification tests development of, for chlamydia, confirmation of positive tests, 372 epidemiologic effects of, future of, inhibitors of, PCR, 368 professional organizations recommendations, 373 strand displacement amplification, 368 transcription mediated amplification, for gonorrhea, cost-effectiveness studies in, 377 cultures, 376 diagnostic specimen pooling in cost savings due to, direct smear examination, future of, partnering in, 378 pelvic examination in, 377 probe hybridization, 376 sample of, P Parental notification laws behavioral interventions for STDs and challenges to, 557 Partner therapy expedited and control, Patient education in STD management in MCOs, PCR. See Polymerase chain reaction (PCR). Peer referral and control, 524, 527 Pelvic examination in gonorrhea detection, 377 Pelvic inflammatory disease (PID) causes of, Mycoplasma genitalium, described, management of, PID. See Pelvic inflammatory disease (PID). Polymerase chain reaction (PCR) for chlamydia, 368 Pregnancy genital HPV infection during, 472 genital HSV infection during diagnostic tests for, Probe hybridization for gonorrhea, 376 Project RESPECT, Q Quality of care of STDs in MCOs, 495 R Risk-reduction counseling in STD management in MCOs, S Selective mass treatment and control, Sexual abuse childhood sexual behavior effects of, Sexual behavior changes in attitudes effects on, changes in expectations effects on, changes in structure of marriage and family effects on, 304 changes in values effects on, childhood sexual abuse effects on, demographic effects on, global socio-political and economic structure effects on, hierarchy effects on, 305 mental health effects on, modern day influences on, technology effects on, Sexually acquired infections in women Mycoplasma genitalium as,

5 INDEX 567 Sexually transmitted diseases (STDs) bacterial prevention and control of innovative approaches to, behavioral interventions, case-finding and treatmentrelated, cluster tracing, 524, 527 expedited partner therapy, female screening in medical care settings, 521 in unconventional locations, Internet-based interventions, 532 male chlamydial screening, 522 mass treatment, microbicides, peer referral, 524, 527 rescreening, behavioral interventions for, behavioral models in, case studies, challenges of, development of challenges in, large-scale intervention studies, objectives of, 548 parental notification laws related to challenges to, 557 problems associated with, Project RESPECT, sexual context impact on, 545 syphilis elimination, 552 Thai 100% Condom Program, Uganda ABC Program, health transition related to, 298 in homosexual men in Western Europe and U.S. epidemiology of changes in, increase in, biologic factors in, demographic trends and, 317 high-risk sexual behavior and, psychosocial contexts and, reasons for, sexual marketplace and, intervention trials for outcomes of HSV type 2 in, prevalence of, risk factors for assessment bias in, sexual behavior and, See also Sexual behavior. treatment of in MCOs, case reporting in, clinical practice guidelines in, described, diagnostic testing in, literature review methods in, 493 management of exposed sex partners, patient education in, quality of care, 495 risk assessment in, risk-reduction counseling in, screening in, study of, discussion of, results of, types of, vaccines for acceptability of, 485 Chlamydia trachomatis, 478 future directions in, HSV, human papillomavirus, Neisseria gonorrhoeae, progress in, Sexually transmitted diseases (STDs)/HIV interactions developments in, Stages of Change Theory, 547 STDs. See Sexually transmitted diseases (STDs).

6 568 INDEX Strand displacement amplification for chlamydia, 368 Syphilis elimination of behavioral interventions for, 552 T Thai 100% Condom Program, Theory of Reasoned Action, Transcription mediated amplification for chlamydia, Trichomoniasis, clinical manifestations of, clinical overview of, 290 complications of, diagnosis of, epidemiology of, , in special populations estimates of, 291 microbiology of, 290 prevalence of population-based estimates of, 291 treatment of, Bethesda System, U Uganda Abstinence/Be Faithful/Use Condoms (Uganda ABC Program), V Vaccine(s) for STDs, See also Sexually transmitted diseases (STDs), vaccines for. Vaginosis bacterial, complications of, diagnosis of, epidemiology of, 393 pathophysiology of, treatment of, Value(s) sexual behavior effects of, W Wart(s) genital external in genital HPV infection counseling for patients with, 472